Ascendis Pharma Bone Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASCENDIS PHARMA BONE, and what generic alternatives to ASCENDIS PHARMA BONE drugs are available?
ASCENDIS PHARMA BONE has one approved drug.
There are six US patents protecting ASCENDIS PHARMA BONE drugs.
There are eighty patent family members on ASCENDIS PHARMA BONE drugs in twenty-seven countries.
Summary for Ascendis Pharma Bone
| International Patents: | 80 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ascendis Pharma Bone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-002 | Aug 9, 2024 | RX | Yes | No | 8,906,847 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-003 | Aug 9, 2024 | RX | Yes | No | 11,857,603 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-003 | Aug 9, 2024 | RX | Yes | No | 11,590,207 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-001 | Aug 9, 2024 | RX | Yes | Yes | 11,890,326 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-002 | Aug 9, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-002 | Aug 9, 2024 | RX | Yes | No | 11,759,504 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Ascendis Pharma Bone | YORVIPATH | palopegteriparatide | SOLUTION;SUBCUTANEOUS | 216490-002 | Aug 9, 2024 | RX | Yes | No | 11,857,603 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ascendis Pharma Bone Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2014122036 | ⤷ Sign Up |
| Australia | 2009209565 | ⤷ Sign Up |
| Brazil | 112019005793 | ⤷ Sign Up |
| European Patent Office | 3981761 | ⤷ Sign Up |
| Russian Federation | 2019112913 | ⤷ Sign Up |
| South Korea | 20230170810 | ⤷ Sign Up |
| Russian Federation | 2019112919 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
